Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,465,102
+$7,086,289 QoQ
Shares Held
501,687
+1020.4% QoQ
Ownership
0.332%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#48
of 294 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Sep 30, 2025CallValue
$375,250
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $1,760,528,411 across 192 Biotechnology names. BHVN ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,804,703 | $240,494,721 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
960,863 | $117,782,586 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
3,157,008 | $111,726,513 | |
| 4 | IMVT |
Immunovant, Inc.
|
2,330,716 | $89,802,487 | |
| 5 | ZLAB |
Zai Lab Ltd
|
3,369,034 | $64,011,646 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,288,053 | $47,799,646 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,222,080 | $45,730,233 | |
| 8 | CYTK |
Cytokinetics Inc
|
457,907 | $39,009,097 |
All Filings in BHVN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,465,102 | 501,687 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $378,813 | 44,777 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $386,987 | 34,277 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $375,250 | 25,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $365,358 | 24,341 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $352,750 | 25,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $456,331 | 32,341 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $544,289 | 22,641 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $131,770 | 2,637 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $109,380 | 2,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $10,938 | 200 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||